gastro-jРоссийский журнал гастроэнтерологии, гепатологии, колопроктологииRussian Journal of Gastroenterology, Hepatology, Coloproctology1382-43762658-6673«Gastro» LLCgastro-j-1527Research ArticleОБМЕН ОПЫТОМEXCHANG OF EXPERIENCEКисломолочные бактерии: роль в регуляции кишечной перистальтикиFermented-milk bacteria: role in intestinal peristalsis regulationШульпековаЮ. О.ShulpekovaYu. O.2010300620102036873Copyright © Шульпекова Ю.О., 20102010Шульпекова Ю.О.Shulpekova Y.O.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.gastro-j.ru/jour/article/view/1527

Цель обзора. Показать роль кисломолочных бактерий, прежде всего родов Lactobacillus, Bifidumbacterium, и продуктов их метаболизма – короткоцепочечных жирных кислот в регуляции перистальтики кишечника.Основные положения. В клинических исследованиях изучено влияние пробиотических штаммов на выраженность симптомов функциональных кишечных расстройств. Наибольшее внимание уделено рассмотрению эффектов штамма Bifidobacterium animalis DN-173 010 (коммерческое название ActiRegularis). Установлено, что пробиотики, содержащие различные штаммы лакто- и бифидобактерий, оказывают мягкое слабительное действие без существенных нежелательных явлений и уменьшают дискомфорт в животе.Заключение. Продукт, содержащий штамм Bifidobacterium animalis DN-173 010 (с коммерческим названием ActiRegularis) эффективен в лечебных и профилактических целях для коррекции частоты и улучшения консистенции стула, уменьшения вздутия живота как при функциональных кишечных расстройствах, так и у практически здоровых людей.

The aim of review

The aim of review. To demonstrate a role of fermented-milk bacteria, first of all Lactobacillus and Bifidumbacterium geni, and their metabolic products – short-chain fatty acids in regulation of peristalsis of the bowel.

Original positions

Original positions. In clinical studies the effect of probiotic strains on severity of symptoms of functional bowel disorders is investigated. The greatest attention is given to the effects of Bifidobacterium animalis DN-173 010 strain (commercial name — ActiRegularis). It was found out, that probiotics containing various strains of Lacto- and Bifidobacteria, have mild purging action without the essential undesirable effects and reduce abdominal dyscomfort.

Conclusion

Conclusion. The product containing Bifidobacterium animalis DN-173 010 strain (commercial name — ActiRegularis) is effective for medical and preventive purposes for correction of frequency and improvement of stool consistence, decrease of abdominal distention both at functional bowel disorders, and at practically healthy people.

пробиотикисиндром раздраженного кишечниказапорprobioticsirritable bowel syndromeconstipationReferencesAgrawal A., Houghton L.A., Morris J. et al. Clinical trial: the effects of a fermented milk product containing Bifidobacterium lactis DN-173 010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation // Aliment. Pharmacol. Ther. – 2008 Sep 17 [Epub. ahead of print].Agrawal A., Houghton L.A., Morris J. et al. Clinical trial: the effects of a fermented milk product containing Bifidobacterium lactis DN-173 010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation // Aliment. Pharmacol. Ther. – 2008 Sep 17 [Epub. ahead of print].Amenta M., Cascio M.T., Di Fiore P., Venturini I. Diet and chronic constipation. Benefits of oral supplementation with symbiotic zir fos (Bifidobacterium longum W11 + FOS Actilight) // Acta Biomed. – 2006. – Vol. 77, N 3. – P. 157–162.Amenta M., Cascio M.T., Di Fiore P., Venturini I. Diet and chronic constipation. Benefits of oral supplementation with symbiotic zir fos (Bifidobacterium longum W11 + FOS Actilight) // Acta Biomed. – 2006. – Vol. 77, N 3. – P. 157–162.Bekkali N.L., Bongers M.E., van den Berg M.M. et al. The role of a probiotics mixture in the treatment of childhood constipation: a pilot study // Nutr. J. – 2007. – Vol. 4, N 6. – P. 17.Bekkali N.L., Bongers M.E., van den Berg M.M. et al. The role of a probiotics mixture in the treatment of childhood constipation: a pilot study // Nutr. J. – 2007. – Vol. 4, N 6. – P. 17.Bixquert Jimйnez M. Treatment of irritable bowel syndrome with probiotics. An etiopathogenic approach at last? // Rev. Esp. Enferm. Dig. – 2009. – Vol. 101, N 8. – P. 553–564.Bixquert Jimйnez M. Treatment of irritable bowel syndrome with probiotics. An etiopathogenic approach at last? // Rev. Esp. Enferm. Dig. – 2009. – Vol. 101, N 8. – P. 553–564.Cherbut C. Effects of short-chain fatty acids on gastrointestinal motility // Physiological and clinical aspects of short-chain fatty acids / Eds. J.H. Cummings, J.L. Rombeau, T. Sakata. – UK: Cambridge, Cambridge Univ. Press, 1995. – P. 191.Cherbut C. Effects of short-chain fatty acids on gastrointestinal motility // Physiological and clinical aspects of short-chain fatty acids / Eds. J.H. Cummings, J.L. Rombeau, T. Sakata. – UK: Cambridge, Cambridge Univ. Press, 1995. – P. 191.Chmielewska A., Szajewska H. Systematic review of randomised controlled trials: probiotics for functional constipation // World J. Gastroenterol. 2010. – Vol. 16, N 1. – P. 69–75.Chmielewska A., Szajewska H. Systematic review of randomised controlled trials: probiotics for functional constipation // World J. Gastroenterol. 2010. – Vol. 16, N 1. – P. 69–75.De Paula J.A., Carmuega E., Weill R. Effect of the ingestion of a symbiotic yogurt on the bowel habits of women with functional constipation // Acta Gastroenterol. Latinoam. – 2008. – Vol. 38, N 1. – P. 16–25.De Paula J.A., Carmuega E., Weill R. Effect of the ingestion of a symbiotic yogurt on the bowel habits of women with functional constipation // Acta Gastroenterol. Latinoam. – 2008. – Vol. 38, N 1. – P. 16–25.Drouault-Holowacz S., Bieuvelet S., Burckel A. et al. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome // Gastroenterol. Clin. Biol. – 2008. – Vol. 32, N 2. – P. 147–152.Drouault-Holowacz S., Bieuvelet S., Burckel A. et al. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome // Gastroenterol. Clin. Biol. – 2008. – Vol. 32, N 2. – P. 147–152.Duez H., Pelletier C., Cools S. et al. A colony immunoblotting method for quantitative detection of a Bifidobacterium animalis probiotic strain in human faeces // J. Appl. Microbiol. – 2000. – Vol. 88, N 6.Duez H., Pelletier C., Cools S. et al. A colony immunoblotting method for quantitative detection of a Bifidobacterium animalis probiotic strain in human faeces // J. Appl. Microbiol. – 2000. – Vol. 88, N 6.– P. 1019–1027.– P. 1019–1027.Guyonnet D., Chassany O., Ducrotte P. et al. Effect of a fermented milk containing Bifidobacterium animalisGuyonnet D., Chassany O., Ducrotte P. et al. Effect of a fermented milk containing Bifidobacterium animalis

The authors declare that there are no conflicts of interest present.